Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-615-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The reliability is rated 1 because the study followed the standard guideline of reference (OECD 422), which describes a procedure designed to evaluate this endpoint, the results were reviewed for reliability and assessed as valid, and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Bis and tris and tetra (4-{bis[4-(dimethylamino)phenyl]methylene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium) [12,21-dihydro-29H,31H-phthalocyanine-bis and tris and tetrasulfonato-k4N29,N30,N31,N32]cuprate
- EC Number:
- 700-615-0
- Molecular formula:
- BIS: C82H74N14CuS2O6 TRIS: C107H103N17CuS3O9 TETRA: C132H132N20CuS4O12
- IUPAC Name:
- Bis and tris and tetra (4-{bis[4-(dimethylamino)phenyl]methylene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium) [12,21-dihydro-29H,31H-phthalocyanine-bis and tris and tetrasulfonato-k4N29,N30,N31,N32]cuprate
- Reference substance name:
- Sepisol Fast Violet 3B
- IUPAC Name:
- Sepisol Fast Violet 3B
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Sepisol Fast Violet 3B
- Substance type: Organocopper
- Physical state: Dark violet powder
- Analytical purity: 99.1 %
- Purity test date: 2012
- Lot/batch No.: 206641
- Expiration date of the lot/batch: 2022
- Stability under test conditions: Stable
- Storage condition of test material: Stored in tightly close container in a dry, cool and well-ventilated area in the utility room
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, USA and bred at IIBAT animal house facility
- Age at study initiation: Between 12 and 14 weeks. Females were virgin
- Weight at study initiation: Males: 361 g to 400 g; Females: 232 g to 274 g.
- Fasting period before study: none
- Housing: Males were housed in groups in cages, each cage containing 5 animals during pre-mating and post-mating period. Females were housed in groups of 5 animals per cage during pre-mating. 1 male and 1 female was kept together in a cage until pregnancy occurs. Pregnant females were caged individually. Animals from reversal group were housed group wise and sex wise with 5 animals per cage.
- Diet: Ad libitum - Standard gamma irradiated pellet food.
- Water: Ad libitum - Reverse osmosis water
- Acclimation period: five days in the test room
- Sanitation: Bedding material, cages, grills were changes once every 3 day and water bottles were changed daily. Cages, grills and water bottles were autoclaved.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.1 °C to 22.1 °C. Recorded once daily
- Humidity (%): 51% - 59%. Recorded once daily
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hrs dark/12 hrs light
IN-LIFE DATES:
- (P) Males groups 1 to 4: From August 16, 2012 to September 13, 2012
- (P) Females groups 1 to 4: From August 16, 2012 to September 26 - September 29, 2012
- Males and females groups 5 and 6: From August 16, 2012 to October 09, 2012
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Sepisol Fast Violet 3B was prepared freshly daily by mixing with corn oil and magnetically stirred to obtain a violet homogenous suspension just before the administration.
VEHICLE
- Justification for use and choice of vehicle : non toxic vehicle which allows an homogenous solution/suspension.
- Amount of vehicle (if gavage): dose volume maintained at 10 mL/kg b.w. - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: until proof of pregnancy (maximum 5 days).
- Proof of pregnancy: vaginal plug and/or sperm in vaginal smear referred to as day 0 of pregnancy
- No unsuccessful attemps.
- After successful mating each pregnant female was caged individually - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- (P) Males groups 1 to 4: 15 days before mating, continously during mating (1 to 5 days) and after mating until the dosing period of 28 days.
(P) Females groups 1 to 4: 15 days before mating, continously during mating (1 to 5 days), during pregnancy (21 to 23 days) and 3 days post partum (Total: from 41 to 44 days)
Males and Females from reversal groups: 41 days (until first scheduled kill of dams) - Frequency of treatment:
- daily
- Details on study schedule:
- (P) Males groups 1 to 4: sacrifice at the end of the exposure period of 28 days.
(P) Females groups 1 to 4: sacrifice at the end of the exposure period of 41 to 44 days
Males and Females of the reversal groups: Maintained for 14 days after dosing period prior sacrifice (sacrifice at day 54). No mating.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
Groups 1 to 4 = 0, 12.5, 25 and 50 mg/kg b.w./day (m/f) respectively
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
Reversal group 0 and 50 mg/kg b.w./day (m/f) respectively
Basis:
nominal conc.
Groups G5 (control reversal) and G6 (high reversal)
- No. of animals per sex per dose:
- (P) Males from groups 1 to 4: 10/group
(P) Females from groups 1 to 4: 10/group
Males and Females from the reversal groups: 5/sex/group - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: doses were selected based on the results of the range finding study carried out.
- Rationale for animal assignment (if not random): Randomization
- Range finding study: 4 groups were selected: one control (G1) and 3 dose groups with 3 males and 3 females of each 100 (G2), 300 (G3) and 1000 (G4) mg/kg b.w. of the test substance, administered oraly for 7 days and observed for morbidity/mortality and signs of toxicity daily. Control group animals were treated similarly, but with corn oil alone.
On day 3, one male and two females, whereas on day 4 one male and one female from group 4 was found dead.
On day 5, one male from G4 and two males and two females from G3 were found dead.
One male and one female from G3 were found dead on Day 6. Bluish perianal stating was observed in all animals of all test substance treated group from day 1 to 7.
Dullness was observed in two male and one female from G2 and all animals of G3 and G4.
Piloerection was noted in two female and one male of G3 and one male and one female of G4.
Abdominal distension was observed in two males and three females from G3 and three males and two females from G4.
Mouth breathing was recorded in three males and two females of G3 and also in three males on one female of G4.
At macroscopic examination, blue discoloration of stomach and intestine The gross lesions observed in the treated group were blue discoloration of stomach and intestine was observed in all treated groups. Small seminal vesicles were noted in G3 and G4 group, dark red discoloration of liver, enlarged adrenals and mesenteric lymph nodes were observed in G3 animals. - Positive control:
- no
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily for all animals, to record any sign of toxicity
- Parameters eximaned: changes in skin, fur, eyes, and mucous membranes, occurrence of secretions, excretions (coloration and intensity of faeces and/or urine) and autonomic activity (e.g. lacrimation, piloerection, palpebral closure, palpebral reflex, pupil light response, and unusual respiratory pattern). Changes in gait, mobility, arousal, rearing, posture, vocalizations, activity levels and response to handling, approach response, touch response, click response, tail pinch response, toe pinch as well as the presence of clonic or tonic movements, stereotypes (e.g. excessive grooming, repetitive circling), bizarre behavior (e.g. self-mutilation, walking backwards), were also recorded. Pertinent behavioral changes, signs of difficult or prolonged parturition and all signs of toxicity, including mortality, were also recorded.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule:
* (P) Males groups 1 to 4: On pre-mating days 0, 7, mating days 0, 7 and 13.
* (P) Females groups 1 to 4: On pre-mating days 0, 7, mating day 0, pregancy days 0, 7, 14, 20 and on post partym day 4.
* Males and females of the reversal groups: On days 0, 7, 14, 21, 28, 35, 42, 49 and on day 53 (at termination).
BODY WEIGHT: Yes
- Time schedule for examinations:
* (P) Males groups 1 to 4: Prior administration, on pre-mating days 0, 7, mating days 0, 7 and at termination
* (P) Females groups 1 to 4: Prior administration, on pre-mating days 0, 7, mating day 0, Pregnancy days 0, 7, 14, 20, within 24 hours of parturition and on post partum day 4
* Males and Females of the reversal groups: Prior administration, on days 7, 14, 21, 28, 35, 42, 49 and on day 53 (at termination).
GROSS PATHOLOGY
- Macroscopical examination for any abnormalities with special attention to reproductive system's organs.
- Record of the number of implantation sites and corpora lutea.
- Tissues preserved in 10 % neutral buffer formalin for histopathological examination: all gross lesions, brain (representative regions including cerebrum, cerebellum and pons), spinal cord, stomach, small and large intestines (including Peyer’s patches), liver, kidneys, adrenals, spleen, heart, thymus, thyroid, trachea and lungs, uterus, urinary bladder, mesenteric lymph nodes, mandibular lymph nodes, peripheral nerve (sciatic), and a section of bone marrow (sternum).
ORGAN WEIGHT
- Weights of following organs of all male animals were recorded: 1. Testes 2. Epididymis
- Weights of following organs for randomly selected five males and five females of group G1, G2, G3, G4 and all animals from groups G5 and G6: Liver, Kidneys, Adrenals, Thymus, Spleen, Brain and Heart.
Other: see the same study in chapter 7.5.1 "Repeated dose toxicity: oral". - Oestrous cyclicity (parental animals):
- not performed
- Sperm parameters (parental animals):
- not performed
- Litter observations:
- Performed for litter produced by females of groups 1 to 4.
Examined as earliest after delivery.
Observation made:
* Numbers and sex
* still and live births
* runts and presence of gross abnormalities
* weighed within 24 hours of parturition and on post partum day 4.
- Postmortem examinations (parental animals):
- SACRIFICE
- (P) Male animals: All surviving animals were sacrificed at the end of the dosing period, i.e. on day 28.
- (P) Maternal animals: All surviving animals were sacrificed at the end of the dosing period, i.e. on post partum day 4.
- Male and female animals of the reversal groups: All surviving animals were sacrified at the end of the 14 days observations period, following the end of the dosing period, i.e. on day 53.
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table [2] were prepared for microscopic examination and weighed, respectively. - Postmortem examinations (offspring):
- External examinations for gross abnormalities.
- Statistics:
- Examined parameters were checked for normality:
- Normal data was subjected to one-way ANOVA
- Non-normal data was subjected to Kruskal-Wallis One-Way ANOVA on Ranks
Student's Newman-Keul's Test was employed for post ANOVA comparison. - Reproductive indices:
- sex ratio: (Number of male pups/ Number of female pups) x 100
- Offspring viability indices:
- not applicable
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Statistical significant decrease in group 4 in males from day 7 to the sacrifice and from day 14 in females but not continued during the gestation and post partum.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Statistical significant decrease in group 4 in males from day 7 to the sacrifice and from day 14 in females but not continued during the gestation and post partum.
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- no treatment related changes observed when compared to concurrent control group
- Other effects:
- no effects observed
- Description (incidence and severity):
- Test substance intake: No statistical sigificant changes when compared to concurrent control group
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No effect in parameters like fertility, mating period, gestation length, mean corpora lutea, mean implantation, mean litter size, mean litter/pup weight, implantation losses and sex ratio of offspring when compared to control.
Details on results (P0)
No mortality.
No clinical signs of toxicity were observed in males and females of G1, G2 and G5 group animals.
The bluish perianal staining in animals of G3, G4 and G6 groups was considered due to the color of test substance and this effect was disappeared in High reversal (G6) group animals at the end of observation after withdrawal of treatment. Further there were no other relevant changes observed to relate this finding as significant. Hence this effect was not considered as adverse effect.
In G3 group animals, intermittent dullness was observed in 5 (10) males, 6 (10) females and piloerection was noted in 2(10) males, 3(10) females. In G4 group animals, dullness was observed in 9(10) males, 10(10) females and piloerection was observed in 8 (10) females. In G6 group animals dullness was observed in 4(5) males, 5(5) females and piloerection was observed in 2(5) males, 2(5) females. These signs were recovered after withdrawal of treatment subsequently in G6 (Table no. 13 of the final repot).
Observed weekly individual clinical signs like home cage, handling and standard arena (open field) were similar to daily observations and did not showed any significance (table no. 6, 14 of the final report).
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Observed body weight in low (G2) and intermediate (G3) dose groups was comparable with respective control group (G1) throughout the observation period. However, statistical significant decrease was observed in G4 & G6 males from day 7 till the sacrifice as compare to their respective control. G4 females of showed decreasing trend body weight from day 7 and continued till end. Statistical significant decrease in the body weight of G6 females was observed from day 14 to the end of the experiment (Table no. 1, 2, 3, 15, 16, 17).
Food consumption recorded in treated groups was comparable with respective control groups and there were no significant difference. (Table 4, 5, 18, 19, 20).
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
Mating was observed within 5 days, which was normal, in all the groups including control. There were no significant changes attributed to the test substance on the mating period (Table 11, 23 of the final report).
No treatment related effect was observed on sex ratio of the pups in any of the treated groups (G2, G3 & G4) when compared with control group (G1) of animals (Table 10, 11, 25 of the final report).
Normal gestation length between 21-23 days was observed in all the treated groups (G2, G3 and G4) when compared with the control group (G1) (Table 24 of the final report).
No statistical significant changes were observed on mean Corpora lutea and Implantations in G2, G3and G4 females when compared to the G1. (Table 9, 10 and 25 of the final report).
Mean litter size of the G2, G3 and G4 was comparable with G1 (Table 25 of the final report).
Mean litter weight of the G2, G3 and G4 was comparable with G1 (Table 10, 25 of the final report).
No test substance related effect was observed on the number of dams delivered with live pups in any of the treated group (G2, G3 and G4) of animals and is comparable with control group (G1) (Tables 10, 11, 25 of the final report).
Loss of offspring (pre implantation, post implantation and post natal) in the treated groups (G2, G3 & G4) was comparable with control (G1) group (Table 9, 10, 11, 25 of the final report).
ORGAN WEIGHTS (PARENTAL ANIMALS)
No test substance related organ weight changes were observed in any of treated group when compared to concurrent control group. (Tables 27, 28, 32 and 33 of the final repot)
GROSS PATHOLOGY (PARENTAL ANIMALS)
No test substance related gross pathological findings were observed.
The gross necropsy findings observed were either related to physiological, agonal to spontaneous, or were incidental and of the type routinely observed in Wistar rats of this age. (Tables 30 and 34 of the final report).
HISTOPATHOLOGY (PARENTAL ANIMALS)
No test substance related histopathological findings were observed.
The histopathologic findings observed were either related to, agonal to spontaneous, or were incidental and of the type routinely observed in Wistar rats of this age. (Tables 31 and 34 of the final report).
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- > 50 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not specified
Details on results (F1)
Gross external examination of live pups sacrificed on day 4 post-partum did not reveal any abnormality that could be attributed to the treatment (Tables 11 and 29 of the final report).
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
The tables are attached in the field "Attached background material", exept for the table 11 below.
Table 11 - Summary of effects on reproduction/development tabular report.
OBSERVATIONS |
Values |
|||
Group |
G1 |
G2 |
G3 |
G4 |
Dose (mg/kg b.w.) |
0 |
12.5 |
25 |
50 |
Pairs started (N) |
10 |
10 |
10 |
10 |
Females showing evidence of copulation (N) |
10 |
10 |
10 |
10 |
Females achieving pregnancy (N) |
10 |
10 |
9 |
10 |
Conceiving days 1-5(N) |
10 |
10 |
10 |
10 |
Conceiving days ≥6-(N) |
0 |
0 |
0 |
0 |
Pregnancy ≤ 21 days(N) |
1 |
3 |
3 |
3 |
Pregnancy =22 days(N) |
9 |
6 |
6 |
6 |
Pregnancy ≥ 23 days (N) |
0 |
1 |
0 |
1 |
Dams with live young born (N) |
10 |
10 |
9 |
10 |
Dams with live young at day 4 pp(N) |
10 |
10 |
9 |
10 |
Corpora lutea/dam (mean) |
14.40 |
13.30 |
14.10 |
14.70 |
Implants/dam (mean) |
13.60 |
12.40 |
12.00 |
13.70 |
Live pups/dam at birth (mean) |
12.30 |
11.20 |
11.67 |
12.40 |
Live pups/dam at day 4 (mean) |
12.20 |
11.20 |
11.56 |
12.40 |
Sex ratio (m/f) at birth (mean) |
103.08 |
98.52 |
150.83 |
144.87 |
Sex ratio (m/f) at day 4 (mean) |
101.42 |
98.52 |
132.49 |
144.87 |
litter weight at birth (mean) |
82.56 |
72.55 |
73.41 |
78.25 |
litter weight at day 4 (mean) |
121.94 |
117.09 |
112.58 |
119.53 |
ABNORMAL PUPS |
|
|||
Dams with 0 (N) |
8 |
9 |
8 |
9 |
dams with 1 ( N) |
2 |
1 |
1 |
1 |
Dams with ≥ 2(N) |
0 |
0 |
0 |
0 |
LOSS OF OFFSPRING |
||||
Pre - implantation (corpora lutea minus implantations) |
|
|||
Females with 0(N) |
4 |
6 |
4 |
5 |
Females with 1(N) |
4 |
2 |
1 |
3 |
Females with 2(N) |
2 |
0 |
3 |
1 |
Females with ≥ 3(N) |
0 |
2 |
2 |
1 |
Pre-natal/ post - implantations (implantations minus live Birth) |
|
|||
Females with 0(N) |
2 |
6 |
1 |
5 |
Females with 1(N) |
4 |
3 |
4 |
1 |
Females with 2(N) |
3 |
0 |
2 |
3 |
Females with ≥3(N) |
1 |
1 |
2 |
1 |
Post-natal (live births minus alive at post-natal day 4) |
|
|||
Females with 0(N) |
9 |
10 |
8 |
10 |
Females with 1(N) |
0 |
1 |
0 |
0 |
Females with 2(N) |
0 |
0 |
0 |
0 |
Females with ≥3(N) |
0 |
0 |
0 |
0 |
Applicant's summary and conclusion
- Conclusions:
- On the basis of the results obtained in the present study, the No Observed Adverse Effect Level (NOAEL) of Sepisol Fast Violet 3B for reproduction/developmental toxicity screening test is considered as 50 mg/kg b.w.
- Executive summary:
Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test in Wistar rats was performed to evaluate Sepisol Fast Violet 3B.
One hundred rats were randomized into six groups, four main groups containing 10 rats/group/sex viz., G1 (Control), G2, G3, G4 (treated groups) and two reversal groups containing 5 rats/group/sex viz., G5 (control reversal) and G6 (High reversal).
The test substance Sepisol Fast Violet 3B was suspended in corn oil and administered by gavage daily at the doses of 12.5, 25 and 50 mg/kg b.w. to the rats belonging to G2 (low), G3 (Low intermediate), G4 (High) and G6 (High reversal) groups respectively. In males dosing was carried out up to 28 days, where as in females test substance was administered during premating, mating, gestation and up to day 3 post partum. Animals from reversal group were dosed up to first sacrifice of dams and kept untreated for 14 days to evaluate the reversibility of effects after withdrawal of the treatment. Control and control reversal groups were treated similarly but with corn oil alone. The dose volume was maintained at 10 ml/kg b.w. in all the groups.
Males were sacrificed after completion of four weeks of dosing (Day 28th) and females were sacrificed on day 4 post partum. Rats in reversal groups were sacrificed after 14 days of additional observation period.
No morbidity/mortality was observed in any of the group.
No clinical signs of toxicity were observed in males and females of G1, G2 and G5 group animals.
The bluish perianal staining observed in G3, G4 and G6 groups was disappeared after withdrawal of treatment in high reversal group (G6).
In G3 group intermittent dullness and piloerection was observed in few animals, however, in G4 and G6 groups these signs were persisted during the treatment and they were recovered after withdrawal of treatment subsequently.
Observed weekly individual clinical signs like home cage, handling and standard arena (open field) were similar to daily observations and did not showed any significance.
Observed body weight in low (G2) and intermediate (G3) dose groups was comparable with respective control group (G1) throughout the observation period. However, statistical significant decrease was observed in G4 & G6 males from day 7 to the sacrifice as compare to their respective control. In G4 females, statistical significant decrease was observed on day 14 but not continued during the gestation and post partum. Statistical significant decrease in the body weight of G6 females was observed from day 14 to the end of the experiment.
No Statistical significant changes were observed in food consumption of treated groups when compared to their respective control groups.
There was no statistically significant difference recorded in the FOB parameters viz. Auditory function, grip strength and locomotor activity of G2, G3 and G6 group animals with respect to their concurrent control group, however in G4 group males a statistically significant decrease in the locomotor activity was observed when compared to G1 males.
Blood was collected on mating day 0 from randomly selected five males and females of main groups and all animals from reversal groups; and on day of scheduled kill of animals from reversal groups, from orbital sinus in heparinized vials (for biochemistry) and in vials containing EDTA (for hematology).
There were no statistical significant changes observed on mating day 0 in females across all the treated groups with respect to their concurrent control groups. However, in males on mating day 0, statistically significant changes were observed in hematology parameters like increase in RBC in G4 males and G3 females, platelet in G4 males when compared to their concurrent controls. However these changes were not observed in the high reversal group, further these values were well within the historical data of IIBAT. Hence these changes were not considered as treatment related.
No statistically significant changes were observed in biochemistry parameters across the groups in both the time points except statistical significant changes in ALT in G4 males, urea, blood urea nitrogen, triglycerides, calcium in G6 males and ALP on mating day 0 and Calcium on day 54 in G6 females as compare to their concurrent controls. These changes were not observed in the dose dependant manner and the values are within the historical data of IIBAT, hence not considered test substance related.
All dams were allowed to litter naturally and the size and weight of litters, live births, runts, sex of live pups and the presence of gross abnormalities were recorded within 24 hours of parturition (day 0) and on day 4 post partum.
No test substance related effect was observed in parameters like fertility, mating period, gestation length, mean corpora lutea, mean implantation, mean litter size, mean litter/pup weight, implantation losses, and sex ratio of offspring in G2,G3 and G4 groups when compared to control.
Gross external examination of live pups sacrificed on day 4 post-partum did not reveal any abnormality that could be attributed to the treatment.
Complete gross pathology was conducted on all adult animals and examined macroscopically for any abnormalities or pathological changes. Special attention was paid to the organs of the reproductive system.
No test substance related gross pathological findings were observed. The gross necropsy findings observed were either related to physiological, agonal to spontaneous, or were incidental and of the type routinely observed in Wistar rats of this age.
Organ weight of testes and epididymis was recorded from all animals while weight of Liver, Kidneys, Adrenals, Thymus, Spleen, Brain and Heart was recorded in randomly selected five males and five females. No treatment related organ weight changes were observed in any of the groups when compared to concurrent control group.
Detailed histological examination in all animals of control and high dose group was performed on the Ovaries, Testes, and Epididymis with special emphasis on stages of spermatogenesis and histopathology of interstitial testicular cell structure. In addition, full histopathological examination was carried out on the selected five males and five females of control and high dose group. Treatment related histopathological findings were not observed. The histopathological findings observed were either related to, agonal to spontaneous, or were incidental and of the type routinely observed in Wistar rats of this age.
On the basis of the results obtained in the present study, the No Observed Adverse Effect Level (NOAEL) of Sepisol Fast Violet 3B for Repeated Dose Toxicity study is considered as 25 mg/kg b.w. whereas, the NOAEL of Sepisol Fast Violet 3B for Reproduction/Developmental Toxicity Screening Test is considered as 50 mg/kg b.w.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.